Sort
21,453 grants matching “tuberculosis”
Therapeutic Restoration of Metabolic Homeostasis During Active TB
$185,875Randall J Basaraba · Colorado State University · R21 · FY2015 · AI
Subcellular Mechanisms for Fungal Phagosome Maturation in Macrophages
$185,872Michael K Mansour · Massachusetts General Hospital · K08 · FY2014 · AI
Dissecting the molecular regulation of T cell localization and function within the Mycobacterium tuberculosis granuloma
$185,835Benjamin Henry Gern · Seattle Children'S Hospital · K08 · FY2024 · AI
Mycobacterium Tuberculosis Lipoarabinomannan In Vivo
$185,771Libin Shi · Colorado State University · R21 · FY2013 · AI
Discovery of antitubercular PptT inhibitors
$185,769Michael D Burkart · University Of California, San Diego · R21 · FY2010 · AI
MR1-dependent presentation of Mycobacterium tuberculosis: a unique role for calcium signaling
$185,760Elham Karamooz · Oregon Health & Science University · K08 · FY2020 · AI
Novel preclinical efficacy models against nontuberculosis mycobacteria
$185,751Diane Joyce Ordway · Colorado State University · R21 · FY2013 · AI
MACROPHAGE COMPLEMENT RECEPTORS IN TUBERCULOSIS
$185,738Ohio State University · R01 · FY2002 · AI
Interhemispheric Research/Training in infectious Disease
$185,687Herbert Bernard Tanowitz · Albert Einstein College Of Medicine · D43 · FY2013 · TW
Emory-Georgia TB Research Training Program
$185,687Henry M Blumberg · Emory University · D43 · FY2013 · TW
Clinical and Economic Outcomes of HIV, Cigarette Smoking, and Smoking Cessation Interventions
$185,670Krishna P Reddy · Massachusetts General Hospital · K01 · FY2017 · DA
Clinical and Economic Outcomes of HIV, Cigarette Smoking, and Smoking Cessation Interventions
$185,670Krishna P Reddy · Massachusetts General Hospital · K01 · FY2019 · DA
Clinical and Economic Outcomes of HIV, Cigarette Smoking, and Smoking Cessation Interventions
$185,670Krishna P Reddy · Massachusetts General Hospital · K01 · FY2018 · DA
Regulation of lipid biosynthesis in Mycobacterium tuberculosis
$185,667John T Belisle · Colorado State University · R21 · FY2012 · AI
Control of latent/persistent HIV-1 infection in macrophages/microglia: A key role for the phosphatase PPM1A
$185,625Olaf Kutsch · University Of Alabama At Birmingham · R21 · FY2022 · DA
The role of Chlamydia trachomatis specific HLA-E restricted CD8 T cell responses in clearance of infection
$185,625Anju Bansal · University Of Alabama At Birmingham · R21 · FY2024 · AI
The splicing factor SF3b1 is a master regulator of the innate immune response to Mycobacterium tuberculosis
$185,625Robert Owen Watson · Texas A&M University Health Science Ctr · R21 · FY2017 · AI
TLR4 Mutations: Molecular Mechanisms of Impaired LPS Sensitivity
$185,625Andrei E Medvedev · University Of Maryland Baltimore · R21 · FY2010 · AI
SUPPORT FOR MYCOBACTERIUM TUBERCULOSIS STUDIES
$185,618Matthews Media Group, Inc. · N01 · FY2000 · AO
CD1 IMMUNE RESPONSES AND VACCINES IN ANIMAL MODELS OF TB
$185,602Brigham And Women'S Hospital · R01 · FY2001 · AI
Targeted next-generation sequencing to enhance detection and genomic characterization of Mycobacterium tuberculosis and high-impact bacterial pathogens among HIV-infected adults with sepsis in Uganda
$185,590Max O'Donnell · Columbia University Health Sciences · R21 · FY2020 · AI
MR1-dependent presentation of Mycobacterium tuberculosis: a unique role for calcium signaling
$185,544Elham Karamooz · Oregon Health & Science University · K08 · FY2021 · AI
MR1-dependent presentation of Mycobacterium tuberculosis: a unique role for calcium signaling
$185,544Elham Karamooz · Oregon Health & Science University · K08 · FY2022 · AI
Engineered Outer Membrane Vesicles as DNA Vaccine Delivery Vehicles
$185,426David A Putnam · Cornell University · R21 · FY2007 · EB
Clinical and Economic Outcomes of HIV, Cigarette Smoking, and Smoking Cessation Interventions
$185,409Krishna P Reddy · Massachusetts General Hospital · K01 · FY2016 · DA